CMS gave 20% on top of the DRG rate if a COVID 19 diagnosis and remdesivir were both on the claim. So if a patient was in ICU and the total bill was $200,000 the hospital would get an additional $40,000 by administering remdesivir. It’s completely unethical to mandate care through use of bonuses for a particular medication. Incentives are usually based on outcomes or results. There is an entire ethical standard to appropriately measuring quality and it is not appropriate to mandate a particular medication.